Raleigh Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-72
| Closed | -$2.52K | – | 793 |
|
|
2024
Q4 | $2.52K | Hold |
72
| – | – | ﹤0.01% | 811 |
|
|
2024
Q3 | $2.88K | Hold |
72
| – | – | ﹤0.01% | 777 |
|
|
2024
Q2 | $3.43K | Hold |
72
| – | – | ﹤0.01% | 719 |
|
|
2024
Q1 | $3.12K | Hold |
72
| – | – | ﹤0.01% | 717 |
|
|
2023
Q4 | $3.64K | Hold |
72
| – | – | ﹤0.01% | 798 |
|
|
2023
Q3 | $3.27K | Hold |
72
| – | – | ﹤0.01% | 742 |
|
|
2023
Q2 | $2.95K | Hold |
72
| – | – | ﹤0.01% | 710 |
|
|
2023
Q1 | $2.57K | Sell |
72
-72
| -50% | -$2.57K | ﹤0.01% | 740 |
|
|
2022
Q4 | $5.44K | Buy |
144
+72
| +100% | +$2.72K | ﹤0.01% | 537 |
|
|
2022
Q3 | $3K | Hold |
72
| – | – | ﹤0.01% | 592 |
|
|
2022
Q2 | $3K | Hold |
72
| – | – | ﹤0.01% | 508 |
|
|
2022
Q1 | $3K | Buy |
+72
| New | +$3K | ﹤0.01% | 516 |
|